Dyne Therapeutics, Inc.

Vivo Capital, LLC DYN

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

2,614,960

Value ($000)

51,149

Weight

3.3%

2025 Q2 - 2025 Q4 (3 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	51,149	3.3%	2,614,960	12/31/2025
2025 Q3	11/14/2025	33,079	2.7%	2,614,960	9/30/2025
2025 Q2	8/14/2025	10,614	1.1%	1,114,960	6/30/2025